Plenary Session:
6. Ebola: Survivorship, the Science, Global Response, and the West African Experience
Wednesday, October 7, 2015: 3:45 PM-6:00 PM
Room: 20--ABCD

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe various sequelae of Ebola Virus Disease
  • discuss the role of viral sequencing in elucidating Ebola virus transmission in West Africa
  • assess the global response to the Ebola outbreak in West Africa
  • summarize the challenges for the lessons learned by West African nations experiencing the Ebola outbreak

Target Audience: Scientists, Vaccinologists, Researchers, Public health practitioners, Pharmacists, Nurses, Microbiologists, Members-in-training, Lab personnel, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, Hospital administrators, HIV specialists, HIV clinicians, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians, Policy Makers

Tracks: Pediatric ID, Investigative ID, HIV-STD-TB, Global ID, Epidemiology and Infection Control, Adult ID, Trainee

Moderators:  James M. Hughes, MD, FIDSA, Emory University , Stephen B. Calderwood, MD, FIDSA, Massachusetts General Hospital and Inger Damon, MD, PhD, FIDSA, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases

Presentations:
3:45 PM
Introductory Remarks
James M. Hughes, MD, FIDSA

4:30 PM
SHEA Senior Scholar Award
Daniel J. Sexton, MD, FIDSA, FSHEA

4:30 PM
IDSA Alexander Fleming Award
Anne Gershon, MD, FIDSA, FPIDS

4:30 PM
HIVMA Clinical Educator Award
Peter Selwyn, MD, MPH
4:30 PM
PIDS Distinguished Service Award
Janet Gilsdorf, MD, FIDSA, FPIDS

4:55 PM
16
5:55 PM
Q&A

CME Credits: Maximum of 2 hours of AMA PRA Category 1 CreditTM

ACPE Credits: No CPE credit is offered for this session

ACPE Number:

Disclosures:

J. M. Hughes, None

S. B. Calderwood, None

I. Damon, None

See more of: Plenary Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.